Pharmacokinetics of doxepin and desmethyldoxepin - An evaluation with the population approach

被引:0
|
作者
Schreeb, KH [1 ]
Meineke, I [1 ]
Meyer-Barner, M [1 ]
Gleiter, CH [1 ]
机构
[1] Univ Gottingen, Dept Clin Pharmacol, D-37075 Gottingen, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
684
引用
收藏
页码:R174 / R174
页数:1
相关论文
共 50 条
  • [41] EFFECT OF SINGLE AND REPEATED DOSES OF ACTIVATED-CHARCOAL ON THE PHARMACOKINETICS OF DOXEPIN
    SCHEININ, M
    VIRTANEN, R
    IISALO, E
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1985, 23 (01) : 38 - 42
  • [42] PHARMACOKINETICS OF CIS-CIS MIVACURIUM - A POPULATION APPROACH
    PARKER, CJR
    HEADRAPSON, AG
    DEVLIN, JC
    HUNTER, JM
    BRITISH JOURNAL OF ANAESTHESIA, 1993, 71 (05) : P766 - P767
  • [43] Pharmacokinetics of sodium tungstate in rat and dog: a population approach
    Le Lamer, S
    Poucheret, P
    Cros, G
    de Richter, RK
    Bonnet, PA
    Bressolle, F
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 294 (02): : 714 - 721
  • [44] Simulations for population pharmacokinetics (PK) model evaluation.
    Gibiansky, L
    Gibiansky, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P26 - P26
  • [45] Population pharmacokinetics of panipenem in neonates and retrospective evaluation of dosage
    Kimura, T
    Kokubun, H
    Nowatari, M
    Matsuura, N
    Sunakawa, K
    Kubo, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (01) : 51 - 59
  • [46] Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine
    Yip, Vincent L. M.
    Pertinez, Henry
    Meng, Xiaoli
    Maggs, James L.
    Carr, Daniel F.
    Park, B. Kevin
    Marson, Anthony G.
    Pirmohamed, Munir
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (06) : 2572 - 2588
  • [47] Toward a Comprehensive Model of ∆9-Tetrahydrocannabinol Pharmacokinetics Using a Population Pharmacokinetics Approach
    Brett C. Ginsburg
    Clinical Pharmacokinetics, 2015, 54 : 129 - 131
  • [48] Toward a Comprehensive Model of Δ9-Tetrahydrocannabinol Pharmacokinetics Using a Population Pharmacokinetics Approach
    Ginsburg, Brett C.
    CLINICAL PHARMACOKINETICS, 2015, 54 (02) : 129 - 131
  • [49] CLINICAL EVALUATION OF DOXEPIN IN ANXIOUS DEPRESSED OUTPATIENTS
    GOLDSTEI.BJ
    PINOSKY, DG
    PSYCHOSOMATICS, 1969, 10 (3P2) : 37 - &
  • [50] CLINICAL EVALUATION DOXEPIN - A NEW PSYCHOTHERAPEUTIC AGENT
    PITTS, NE
    PSYCHOSOMATICS, 1969, 10 (3P1) : 164 - &